Jennifer A. Wargo, MD, MMSc

Surgical Oncology and Genomic Medicine
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Presentation(s):

• TIP6. Metronidazole to optimize the microbiome of patients with rectal adenocarcinoma undergoing neoadjuvant therapy: protocol for the phase II MONARCH trial

  Friday, March 6, 2026
  3:51 PM - 3:55 PM MST